Canine T-Zone Lymphoma: Unique Immunophenotypic Features, Outcome, and Population Characteristics
Open Access
- 1 May 2014
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 28 (3) , 878-886
Abstract
Background: Canine T-cell lymphoma (TCL) is clinically and histologically heterogeneous with some forms, such as T-zone lymphoma (TZL), having an indolent course. Immunophenotyping is an important tool in the classification of TCL in people, and can be equally useful in dogs. Hypothesis/Objectives: We hypothesized that loss of expression of the CD45 antigen is a specific diagnostic feature of TZL. Animals: Twenty dogs with concurrent histology and immunophenotyping by flow cytometry were studied in depth. An additional 494 dogs diagnosed by immunophenotyping were used to characterize the population of dogs with this disease. Methods: Lymph node biopsies from 35 dogs with TCL were classified by 2 pathologists using WHO criteria. Twenty lymph nodes were from dogs with CD45− TCL and 15 were from CD45+ TCL. The pathologists were blinded to the flow cytometry findings. Outcome information was sought for the 20 dogs with CD45− lymphoma, and population characteristics of the additional 494 dogs were described. Results: All 20 CD45− cases were classified as TZL. The 15 CD45+ cases were classified as aggressive TCL and are described in an accompanying paper. TZL cases had a median survival of 637 days. Examination of 494 additional dogs diagnosed with TZL by immunophenotyping demonstrated that 40% of cases are in Golden Retrievers, are diagnosed at a median age of 10 years, and the majority have lymphadenopathy and lymphocytosis. Conclusions: TZL has unique immunophenotypic features that can be used for diagnosis.Keywords
This publication has 32 references indexed in Scilit:
- Class II Major Histocompatibility Complex Expression and Cell Size Independently Predict Survival in Canine B-Cell LymphomaJournal of Veterinary Internal Medicine, 2011
- Classification of Canine Malignant Lymphomas According to the World Health Organization CriteriaVeterinary Pathology, 2010
- Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHOVeterinary and Comparative Oncology, 2010
- Canine Lymphoproliferative Disease Characterized by Lymphocytosis: Immunophenotypic Markers of PrognosisJournal of Veterinary Internal Medicine, 2008
- Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometryVeterinary Immunology and Immunopathology, 2008
- Canine Indolent Nodular LymphomaVeterinary Pathology, 2006
- Pathobiology of Peripheral T-cell LymphomasHematology-American Society Hematology Education Program, 2006
- CD45: A Critical Regulator of Signaling Thresholds in Immune CellsAnnual Review of Immunology, 2003
- An approach to diagnosis of T‐cell lymphoproliferative disorders by flow cytometryCytometry, 2002
- Peripheral T‐cell non‐Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T‐zone lymphomaBritish Journal of Haematology, 1994